AV

Avanos Medical IncNYSE AVNS Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

1.09

Small

Exchange

XNYS - New York Stock Exchange, Inc

AVNS Stock Analysis

AV

Uncovered

Avanos Medical Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

44/100

Low score

Market cap $B

1.09

Dividend yield

Shares outstanding

46.599 B

Avanos Medical, Inc. is a medical technology company. The company is headquartered in Alpharetta, Georgia and currently employs 4,044 full-time employees. The company went IPO on 2014-10-21. The firm offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The company develops, manufactures and markets its brands globally. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Its respiratory health products include closed airway suction systems and other airway management devices marketed under the Ballard, Microcuff and Endoclear brands. Its acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. Its interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.

View Section: Eyestock Rating